Blog

Al-Ola Abdallah: Introduction to U.S. Myeloma Innovations Research Collaborative Group

Al-Ola Abdallah/LinkedIn

Aug 24, 2024, 10:20

Al-Ola Abdallah: Introduction to U.S. Myeloma Innovations Research Collaborative Group

Al-Ola Abdallah, Associate Professor Of Medicine at the University of Kansas Medical Center, shared a post on LinkedIn:

“Evaluating real-world Outcomes, Access Barriers and Scientific Progress: Introduction to U.S. Myeloma Innovations Research Collaborative (USMIRC) Group.

by Daniyal Shahid, Zain Anwar, and Nausheen Ahmed.”

Read further.
Source: Al-Ola Abdallah/LinkedIn

Al-Ola Abdallah cancer Daniyal Shahid Nausheen Ahmed OncoDaily Oncology U.S. Myeloma Innovations Research Collaborative Group University of Kansas Medical Center USMIRC Group Zain Anwar

Senator Edward Markey in Response to OncoDaily About Pediatric Cancer Funding

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity